Fortune December 30, 2020
What should we do about the financial burden of health care? This question has vexed our political class for decades. Not even the passage of Obamacare in 2010 has managed to settle the issue. Now President-elect Biden will get a turn to address our nation’s most intractable long-run challenge. To succeed where others have failed, Biden should focus on a solution that improves health outcomes while reducing the cost of care—treating biological aging.
The fundamental problem with health care in the U.S. is that it is expensive. In 2018, the latest year for which data is available record, national health expenditures stood at 17.7% of GDP—$3.6 trillion. Politicians vigorously debate whether and to what extent consumers, employers, or the government...
Today's Sponsors
Today's Sponsor